Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
Stocktwits on MSN

SENS shares surge after first commercial patients use AID-integrated continuous glucose monitor system

Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.
Drug Delivery Business

Senseonics launches Eversense 365 CGM with Sequel twiist pump

Senseonics (NYSE:SENS) announced today that it began the launch of its Eversense 365 sensor with the Sequel Med Tech twiist ...

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management. Pairing twiist™ with Senseonics’ ...

New Dexcom CEO wants you to wear a glucose monitor

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.
Le Lézard

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

Assessing DexCom (DXCM) Valuation As Shares Lag Over The Past Year

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...